Skip to main content

Find Clinical Trials

Home
Conditions
Anemia

Clinical trial condition

Anemia

Explore clinical trials studying Anemia. Study availability and eligibility vary by location and protocol.

1,253 public trials 104 recruiting studies

Refine in advanced search Browse all conditions

Anemia trial results

Completed

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

NCT00001533

Conditions: Agranulocytosis, Anemia, Blood Platelet Disorders, +19 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Study on Preventing Anemia in Children in Ghana

NCT00301054

Conditions: Anaemia in Children, Anemia, Hematologic Diseases, +7 more
Locations: District Health Directorate Berekum, Brong- Ahafo, Ghana

View Trial Details

Completed

The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT

NCT00002302

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: AIDS Research Consortium of Atlanta Atlanta, Georgia, United States

Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

Treatment Program for Anemia in AIDS Patients

NCT00002022

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: R W Johnson Pharmaceutical Research Institute Raritan, New Jersey, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia

NCT00002042

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anemia, +19 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002072

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic

NCT00002303

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anemia, +19 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002071

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

NCT00002073

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +18 more
Locations: Ortho Pharmaceutical Corp Raritan, New Jersey, United States

View Trial Details

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period

NCT05175105

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Stanford Medicine Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's Healthcare of Atlanta - Emory Atlanta, Georgia, United States

UChicago Medicine Chicago, Illinois, United States

View all 19 locations

View Trial Details